Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Growth hormones with prolonged in-vivo efficacy

Growth hormones with prolonged in-vivo efficacy

US Patent 8841249 · Granted Sep 23, 2014

Estimated economic value: $13,878,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Protein conjugates2022
GLP-1 compounds2018
Antagonistic DR3 ligands2017
Antagonistic DR3 ligands2017
Antagonistic DR3 ligands2017
Antagonistic DR3 ligands2017
Growth hormones with prolonged in-vivo efficacy2017
Growth hormones with prolonged in-vivo efficacy2017
Growth hormones with prolonged in-vivo efficacy2017
Conjugated proteins2016
Conjugated FVIII variants2015
Conjugated proteins with prolonged in vivo efficacy2014